Laman UtamaAKBLF • OTCMKTS
add
ALK-Abello A/S
Tutup sebelumnya
$25.31
Julat tahun
$19.90 - $27.03
Permodalan pasaran
33.20B DKK
Bilangan Purata
69.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
CPH
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (DKK) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.52B | 12.66% |
Perbelanjaan pengendalian | 547.00J | -4.54% |
Pendapatan bersih | 354.00J | 52.59% |
Margin untung bersih | 23.26 | 35.47% |
Pendapatan bagi setiap syer | 1.60 | 45.45% |
EBITDA | 540.00J | 41.36% |
Kadar cukai berkesan | 25.16% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (DKK) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 517.00J | 77.66% |
Jumlah aset | 8.19B | 20.70% |
Jumlah liabiliti | 2.51B | 19.96% |
Jumlah ekuiti | 5.68B | — |
Syer tertunggak | 221.19J | — |
Harga kepada buku | 0.99 | — |
Pulangan pada aset | 14.27% | — |
Pulangan pada modal | 17.99% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (DKK) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 354.00J | 52.59% |
Tunai daripada operasi | 389.00J | 37.46% |
Tunai daripada pelaburan | -59.00J | 65.70% |
Tunai daripada pembiayaan | -399.00J | -34.80% |
Perubahan bersih dalam tunai | -72.00J | 60.66% |
Aliran tunai bebas | 256.12J | 39.10% |
Perihal
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
Diasaskan
1923
Tapak web
Pekerja
2,736
